ACR Appropriateness Criteria Hodgkin Lymphoma — Favorable Prognosis Stage I and II

A clinical practice guideline for patients with favorable-prognosis stage I and II Hodgkin lymphoma. The guideline examines the use of combined modalities therapy to treat Hodgkin lymphoma, including a focus on optimization of duration and volume. Outcomes of interest include improved tumour control rate and reduced number of cycles in appropriate cases.